Pancreatic Cancer Research

ResearcherSanofi (France)No recent work listed

Timm Denecke

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-3313-3208; OpenAlex author ID A5068189608. Sources: OpenAlex.

Their work

Papers
10 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
18
Papers, trials and grants by year

2014: 1 paper · 2015: 3 papers · 2016: 1 paper · 2017: 1 paper · 2018: 3 papers · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 10

  1. Benefits of Dual-Layer Spectral CT Imaging in Staging and Preoperative Evaluation of Pancreatic Ductal Adenocarcinoma. First author DOI 10.3390/jcm12196145↗
  2. Safety and efficacy of Nab-paclitaxel plus gemcitabine in patients with advanced pancreatic cancer suffering from cholestatic hyperbilirubinaemia-A retrospecti… Co-author DOI 10.1016/j.ejca.2018.06.001↗
  3. Routine portal vein resection for pancreatic adenocarcinoma shows no benefit in overall survival. Co-author DOI 10.1016/j.ejso.2018.05.002↗
  4. The role of hepatectomy for synchronous liver metastases from pancreatic adenocarcinoma. Co-author DOI 10.1016/j.suronc.2018.09.004↗
  5. Incidence and Oncological Implications of Previously Undetected Tumor Multicentricity Following Pancreaticoduodenectomy for Pancreatic Adenocarcinoma in Patien… Co-author DOI 10.21873/anticanres.11952↗
  6. Perioperative treatment options in resectable pancreatic cancer - how to improve long-term survival. Co-author DOI 10.4251/wjgo.v8.i3.248↗
  7. Cytoreductive Surgery for Pancreatic Cancer Improves Overall Outcome of Gemcitabine-Based Chemotherapy. Co-author DOI 10.1097/mpa.0000000000000365↗
  8. CT and MRI Findings of Autoimmune Polymorph Bifocal Pancreatitis Mimicking Pancreatic Adenocarcinoma: A Case Report and Review of the Literature. Co-author DOI 10.1177/2324709615576988↗
  9. Efficacy of Prophylactic Low-Molecular Weight Heparin for Ambulatory Patients With Advanced Pancreatic Cancer: Outcomes From the CONKO-004 Trial. Co-author DOI 10.1200/jco.2014.55.1481↗
  10. Radiologic resectability assessment in pancreatic cancer. Co-author DOI 10.1055/s-0033-1350190↗

Closest collaborators

The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Marcus Bahra · 8 shared papers, 2014–2018 · strength 0.55
  2. Uwe Pelzer · 6 shared papers, 2015–2018 · strength 0.39
  3. Fritz Klein · 5 shared papers, 2015–2018 · strength 0.36
  4. Marianne Sinn · 5 shared papers, 2015–2018 · strength 0.31
  5. Constantin Ehrengut · 1 shared paper, 2023 · strength 0.31
  6. Hans‐Jonas Meyer · 1 shared paper, 2023 · strength 0.31
  7. Hanno B. Riess · 4 shared papers, 2015–2018 · strength 0.24
  8. Thomas Malinka · 2 shared papers, 2018 · strength 0.16
  9. Andréas Andreou · 2 shared papers, 2017–2018 · strength 0.14
  10. Rosa Bianca Schmuck · 2 shared papers, 2017–2018 · strength 0.14
  11. Christian Grieser · 2 shared papers, 2014–2015 · strength 0.13
  12. Matthäus Felsenstein · 1 shared paper, 2018 · strength 0.09
  13. Anja Jühling · 1 shared paper, 2018 · strength 0.08
  14. Jana Käthe Striefler · 1 shared paper, 2018 · strength 0.08
  15. Benjamin Struecker · 1 shared paper, 2018 · strength 0.07
  16. Roman Rotzinger · 1 shared paper, 2015 · strength 0.06
  17. Jens Stieler · 1 shared paper, 2015 · strength 0.04
  18. Helmut Oettle · 1 shared paper, 2015 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.